Slate Path Capital’s Endo International plc ENDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-3,380,000
Closed -$12.5M 38
2020
Q1
$12.5M Buy
3,380,000
+3,030,000
+866% +$15.3M 0.96% 14
2019
Q4
$1.64M Buy
+350,000
New +$1.56M 0.09% 26
2014
Q3
Sell
-1,110,000
Closed -$77.7M 25
2014
Q2
$77.7M Sell
1,110,000
-1,105,000
-50% -$73.9M 2.17% 12
2014
Q1
$152M Sell
2,215,000
-1,560,000
-41% -$111M 11.51% 2
2013
Q4
$255M Buy
3,775,000
+500,000
+15% +$28.5M 8.79% 3
2013
Q3
$149M Buy
3,275,000
+505,000
+18% +$20.3M 7.75% 4
2013
Q2
$102M Buy
+2,770,000
New +$99.6M 5.51% 8

Other funds holding ENDP

Slate Path Capital's ENDP Position: Q2 2020 in Review

Slate Path Capital sold out of Endo International plc (ENDP) in Q2 2020, closing a stake of 3,380,000 shares — an estimated $12.5M sold.

Slate Path Capital first reported a position in ENDP in Q2 2013 and held it in 7 quarters. The position peaked at $255M in Q4 2013. 195 funds tracked by Wall St. Rank hold ENDP as of Q2 2020.

  • Slate Path Capital reported no remaining Endo International plc position as of Q2 2020 after selling out during the quarter.
  • Slate Path Capital sold 3,380,000 Endo International plc shares in Q2 2020, an estimated $12.5M.
  • Slate Path Capital first reported a position in Endo International plc in Q2 2013 and held it in 7 quarters.
  • Slate Path Capital's Endo International plc position peaked at $255M in Q4 2013.
  • 195 funds tracked by Wall St. Rank held Endo International plc as of Q2 2020.

Based on Slate Path Capital's 13F filing for Q2 2020, filed 14 Aug 2020.